Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by BlueMetal75on May 08, 2019 6:41pm

145 Views

Post# 29726462

RE:European Conferences on BIOMEDICAL OPTICS 23–27 June 2019

Glad to see that Dr. Lilge is presenting on the first day, June 23. That should give him plenty of time to get back across the pond for the AGM in Toronto on June 27. Hopefully he will present at the AGM as well.

I'm seriously looking at attending the AGM.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"